Abstract
The aim of this chapter is to bring together data on opioid ligands that (1) antagonize the actions of morphine and its surrogates, (2) possess both agonist and antagonist properties, and (3) possess the unique pharmacological profile of the so-called kappa (κ) agonists. The majority of these compounds fall within the morphine, morphinan, or benzomorphan groups of opioid ligands (Chapters 2, 3, and 4). The topic of narcotic antagonists and dualists has been extensively reviewed up to 1976(1) and only a resumé of the earlier work is presented here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
S. Archer and L. S. Harris, Prog. Med. Chem. 8, 262 (1965).
S. Archer and W. F. Michne, Prog. Med. Chem. 20, 45 (1976).
L. A. Woods, Pharmacol. Rev. 8, 175 (1956).
K. Unna, J. Pharmacol. Exp. Ther. 79, 27 (1943).
J. Weijlad and A. E. Erickson, J. Am. Chem. Soc. 64, 869 (1942).
J. Weijlad and A. E. Erickson, K. Unna, J. Pharmacol Exp. Ther. 79, 27 (1943).
H. Schapiro and J. M. Beal, Surgery 34, 870 (1953).
Martindale: The Extra Pharmacopoeia, 28th ed., pp. 1002, 1031, The Pharmaceutical Press, London (1982).
A. S. Keats and J. C. Mithoefer, Fed. Proc. 14, 356 (1955).
L. Lasagna and H. K. Beecher, J. Pharmacol. Exp. Ther. 112, 356 (1954).
A. S. Keats and J. Telford, J. Pharmacol. Exp. Ther. 117, 190 (1956).
W. R. Martin and C. W. Gorodetzky, J. Pharmacol. Exp. Ther. 150, 437 (1965).
A. H. Beckett and A. F. Casy, Prog. Med. Chem. 4, 171 (1965).
B. M. Cox and M. Weinstock, Br. J. Pharmacol. 22, 289 (1964).
L. Grumback and H. I. Chernov, J. Pharmacol. Exp. Ther. 149, 385 (1965).
J. Pearl and L. S. Harris, J. Pharmacol. Exp. Ther. 154, 319 (1960).
J. Pearl, M. D. Aceto, and L. S. Harris, J. Pharmacol. Exp. Ther. 160, 217 (1968).
J. Pearl, H. Stander, and D. B. McKean, J. Pharmacol. Exp. Ther. 167, 9 (1969).
H. Blumberg, P. S. Wolf and H. B. Dayton, Proc. Soc. Exp. Biol Med. 118, 763 (1965).
R. I. Taber, D. D. Greenhouse and S. Irwin, Nature, 204, 189 (1964).
H. O. C. Collier, L. C. Dinneen, C. A. Johnson and C. Schneider, Br. J. Pharmacol. 32, 295 (1968).
H. I. Chernov, D. E. Wilson, F. Fowler, and A. J. Plummer, Arch. Int. Pharmacodyn. Ther. 167, 171 (1967).
W. L. Dewey and L. S. Harris, J. Pharmacol. Exp. Ther. 179, 652 (1971).
S. I. Ankier, R. D. E. Sewell, and P. S. J. Spencer, Eur. J. Pharmacol. 27, 1 (1974).
S. I. Ankier, R. D. E. Sewell, and P. S. J. Spencer, Prog. Med. Chem. 14, 249 (1977).
T. D. Perrine, L. Atwell, I. B. Tice, A. E. Jacobson, and E. L. May, J. Pharm. Sci. 61, 86 (1972).
H. W. Kosterliz and A. J. Watt, Br. J. Pharmacol. 33, 266 (1968).
H. W. Kosterlitz and A. A. Waterfield, Ann. Rev. Pharmacol. 15, 29 (1975).
J. Hughes, H. W. Kosterlitz, and F. M. Leslie, Br. J. Pharmacol. 51, 139 (1974).
G. W. Pasternak and S. R. Childers, in: Recent Advances in Clinical Pharmacology (P. Turner and D. G. Shand, eds.), p. 257, Churchill Livingstone, Edinburgh (1983).
M. A. Iorio and A. F. Casy, J. Med. Chem. 21, 812 (1978) and refs. cited.
I. Monkovic, H. Wong, A. W. Pircio, Y. G. Perron, I. J. Pachter, and B. Belleau, Can. J. Chem. 53, 3094 (1975).
S. K. Sharma, M. Nirenberg, and W. A. Klee, Proc. Natl. Acad. Sci. USA 72, 590 (1975).
C. A. Winter, P. D. Orahovats, and E. G. Lehman, Arch. Int. Pharmacodyn. Therap. 110, 186 (1957).
R. L. Clark, A. A. Pessolano, J. Weijland, K. Pfister 3rd, J. Am. Chem. Soc. 75, 4963 (1953).
G. F. Blane, A. L. A. Boura, A. E. Fitzgerald, and R. E. Lister, Br. J. Pharmacol. 30, 11 (1967).
J. W. Lewis, in: Narcotic Antagonists, p. 123 (M. C. Brande, L. S. Harris, E. L. May, J. P. Smith, and J. E. Villareal, eds.), Raven Press, New York (1974).
G. F. Blane, A. L. A. Boura, E. C. Leach, W. D. Gray, and A. C. Osterberg, J. Pharm. Pharmacol. 20, 798 (1968).
W. F. Michne, R. L. Salsbury, and S. J. Michalec, J. Med. Chem. 20, 682 (1977).
A. Cowan, in: Narcotic Antagonists, p. 427 (1974) (see ref. 26).
A. Cowan, J. W. Lewis, and I. R. Macfarlane, Br. J. Pharmacol. 60, 537 (1977).
A. Cowan, J. C. Doxey, and E. J. R. Harry, Br. J. Pharmacol. 60, 547 (1977).
J. M. Habrook and M. J. Rance, in: Opiates and Endogenous Opioid Peptides (H. W. Kosterlitz, ed.), p. 295, Elsevier, North-Holland, Amsterdam (1976).
S. C. Clarke, D. R. Jasinski, J. S. Pevnick, and J. D. Griffith, Clin. Pharmacol. Ther. 19, 295 (1976).
M. P. Kotick, D. L. Leland, J. O. Polazzi, and R. N. Schut, J. Med. Chem. 23, 166 (1980).
D. L. Leland and M. P. Kotick, J. Med. Chem. 24, 717 (1981).
J. Quick, P. Herihly, R. K. Razdan, and J. F. Howes, J. Med. Chem. 25, 983 (1982).
U. Weiss, J. Am. Chem. Soc. 77, 5891 (1955).
M. J. Lewenstein, Br. Pat. 955, 493; Chem. Abstr. 61, 4410c (1964).
I. Iijima, J. Minamikawa, A. E. Jacobson, A. Brossi, and K. C. Rice, J. Med. Chem. 21, 398 (1978).
A. E. Takermori, H. J. Kupferberg, and J. W. Miller, J. Pharmacol. Exp. Ther. 169, 39 (1969).
R. J. Kobylecki, R. W. Carling, J. A. H. Lord, C. F. C. Smith, and A. C. Lane, J. Med. Chem. 25, 116 (1982).
F. F. Foldes, Med. Clin. N Amer. 48, 421 (1964).
F. F. Foldes, M. Schapira, T. A. G. Torda, D. Duncalf, and H. P. Shiftman, Anesthesiology, 26, 320 (1965).
L. Lasagna, Proc. Roy. Soc. Med. 58, 978 (1965).
D. R. Jasinksi, W. R. Martin, and C. A. Haertzen, J. Pharmacol. Exp. Ther. 157, 420 (1967).
J. Fishman, M. L. Cotter, and B. I. Norton, J. Med. Chem. 16, 556 (1973).
H. Blumberg, I. J. Pachter, and Z. Matossian, US Patent 3,332,950 (1967).
J. B. Jiang, R. H. Hanson, P. S. Portoghese, and A. E. Takemori, J. Med. Chem. 20, 1100 (1977).
J. K. Errick and R. C. Heel, Drugs 26, 191 (1983).
R. R. Miller, Am J. Hosp. Pharm. 37, 942 (1980).
E. F. Hahn, J. Fishman, and R. D. Heilman, J. Med. Chem. 18, 259 (1975).
N. Chatterjie, C. E. Inturris, H. B. Dayton, and H. Blumberg, J. Med. Chem. 18, 490 (1975).
J. M. Fujimoto, J. Pharmacol. Exp. Ther. 168, 180 (1969).
J. M. Fujimoto, Proc. Soc. Exp. Med. Biol 133, 317 (1970).
E. J. Cone, C. W. Gorodetsky, and S. Y. Yeh, J. Pharm. Sci. 64, 618 (1975).
R. J. Sime, M. Dobler, and R. L. Sime, Acta Crystallog. B32, 809 (1976).
G. W. Pasternak and E. F. Hahn, J. Med. Chem. 23, 674 (1980).
G. W. Pasternak, S. R. Childers, and S. H. Snyder, J. Pharmacol. Exp. Ther. 214, 455 (1980).
G. S. F. Ling, K. Spiegel, S. L. Nishimura, and G. W. Pasternak, Eur. J. Pharmacol. 86, 487 (1983).
E. F. Hahn, M. Carroll-Buatti, and G. W. Pasternak, J. Neuroscience 2, 572 (1982).
E. F. Hahn and G. Pasternak, Life Sci. 31, 1385 (1982).
K. Fromherz and B. Pellmount, Experientia 8, 394 (1952).
J. Hellerbach, A. Griissner, and O. Schneider, Helv. Chim. Acta 39, 429 (1956).
A. S. Keats, private communication.
W. Leimgruber, E. Mohacsi, H. Baruth, and L. O. Randall, in: Narcotic Antagonists, p. 48 (1974) (see réf. 26).
L. Lasagna, Proc. Roy. Soc. Med. 58, 978 (1965).
W. W. White, R. Megirian, and P. S. Marcus, Proc. Soc. Exp. Biol. Med. 92, 512 (1956).
J. O. Polazzi, R. M. Schut, M. P. Kotick, J. F. Howes, P. F. Osgood, R. K. Razdan, and J. E. Villareal, J. Med. Chem. 23, 174 (1980).
D. L. Leland and M. P. Kotick, J. Med. Chem. 23, 1427 (1980).
M. Gates and W. G. Webb, J. Am. Chem. Soc. 80, 1186 (1958).
M. Gates and T. A. Montzka, J. Med. Chem. 7, 127 (1964).
B. Belleau, in: Chemical Regulation of Biological Mechanisms (A. M. Creighton and S. Turner, eds.), p. 200, Royal Society of Chemistry, London (1982).
Y. Lambert, J.-P. Daris, I. Monkovic and A. W. Pircio, J. Med. Chem. 21, 423 (1978).
I. Monkovic, T. T. Conway, H. Wong, Y. G. Perron, I. J. Pachter, and B. Belleau, J. Am. Chem. Soc. 95, 7910 (1973).
I. Monkovic, H. Wong, B. Belleau, I. J. Pachter, and Y. G. Perron, Can. J. Chem. 53, 2515 (1975).
I. Monkovic, H. Wong, A. W. Pircio, Y. G. Perron, I. J. Pachter, and B. Belleau, Can. J. Chem. 53, 3094 (1975).
F. S. Caruso, A. W. Pircio, H. Madissoo, R. D. Smythe, and I. J. Pachter, in: Pharmacological and Biochemical Properties of Drug Substances (M. E. Goldberg, ed.), Vol 2, p. 19, American Pharmaceutical Association, Washington, D. C. (1979).
M. Gordon, J. J. Lafferty, D. H. Tesdeschi, N. B. Eddy, and E. L. May, Nature 192, 1089 (1961).
S. Archer, N. F. Albertson, L. S. Harris, A. K. Pierson, J. G. Bird, A. S. Keats, J. Telford, and C. Papadopoulos, Science 137, 541 (1962).
G. W. Pasternak, M. Carroll-Bua Hi, and K. Spiegel, J. Pharmacol. Exp. Ther. 219,192 (1981).
Anon, Drugs, Basel 5 (1973).
N. F. Albertson, in: Narcotic Antagonists, p. 76 (1974), (see ref. 26).
N. F. Albertson, J. Med. Chem. 18, 619 (1975).
M. Saucier, J.-P. Daris, Y. Lambert, I. Monkovic, and A. W. Pircio, J. Med. Chem. 20, 676 (1977).
W. F. Michne and N. F. Albertson, J. Med. Chem. 15, 1278 (1972).
J. J. Fanley and J. B. Lapidus, J. Med. Chem. 16, 181 (1973).
F. H. Clarke, R. T. Hill, J. K. Saelens, and N. Yokoyama, in: Narcotic Antagonists, p. 81 (1974), (see ref. 26).
S. Archer, N. F. Albertson, L. S. Harris, A. K. Pierson, and J. G. Bird, J. Med. Chem. 7, 123 (1964).
A. de Meijere, Angew. Chem. Int. Ed. Engl. 18, 809 (1979).
B. C. Joshi, C. F. Chignell, and E. L. May, J. Med. Chem. 8, 694 (1965).
K. C. Rice, W. A. Klee, M. D. Aceto, H. H. Swain, and A. E. Jacobson, J. Pharm. Sci. 66, 193 (1977).
M. Gordon, J. J. Lafferty, D. H. Tedeschi, B. M. Sutton, N. B. Eddy, and E. L. May, J. Med. Pharm. Chem. 5, 633 (1962).
H. Merz, A. Langbein, K. Stockhaus, G. Walter, and H. Wick, in: Narcotic Antagonists, p. 91 (1974), (see ref. 26).
H. Merz, K. Stockhaus, and H. Wick, J. Med. Chem. 18, 996 (1975).
Merz, K. Stockhaus, and H. Wick, 20, 844 (1977).
E. L. May and N. B. Eddy, J. Med. Chem. 9, 851 (1966).
J. H. Ager, A. E. Jacobson, and E. L. May, J. Med. Chem. 12, 288 (1969).
E. L. May and M. Takeda, J. Med. Chem. 13, 805 (1970).
W. F. Michne, J. Med. Chem. 21, 1323 (1978).
W. F. Michne, R. T. Lewis, S. J. Michalec, A. K. Pierson, and F. J. Rosenberg, J. Med. Chem. 22, 1158 (1979).
P. Osei-Gyimah, S. Archer, M. G. C. Gillan, and H. W. Kosterlitz, J. Med. Chem. 24, 212 (1981).
H. Schmidhammer, A. E. Jacobson, L. Atwell, and A. Brossi, Heterocycles 16, 1859 (1981); A. E. Jacobson, private communication.
D. L. Lattin, B. Caviness, R. G. Hudson, D. L. Greene, P. K. Raible, and J. B. Richardson, J. Med. Chem. 24, 903 (1981).
A. F. Casy, A. B. Simmonds, and D. Staniforth, J. Pharm. Pharmacol, 20, 768 (1968); D. Staniforth and A. F. Casy, unpublished results.
T. Oh-Ishi and E. L. May, J. Med. Chem. 16, 1376 (1973).
H. W. Kosterlitz, F. M. Leslie, and A. A. Waterfield, J. Pharm. Pharmacol. 27, 73 (1975).
A. Langbein, H. Merz, K. Stockhaus, and H. Wick, in: Narcotic Antagonists, p. 157 (1974) (see ref. 26).
H. H. Ong, T. Oh-Ishi, and E. L. May, J. Med. Chem. 17, 133 (1974).
H. Tecle and G. Hite, Proc. 38th Ann. Sci. Meet. Committee on Problems of Drug Dependence, p. 464 (1976).
D. M. Zimmerman, R. Nickander, J. S. Horng, and D. T. Wong, Nature, 275, 332 (1978).
M. A. Iorio and A. F. Casy, J. Pharm. Pharmacol. 27, 140 (1975).
M. A. Iorio and A. F. Casy, J. Med. Chem. 21, 812 (1978).
F. R. Ahmed, M. A. Iorio, and A. F. Casy, J. Pharm. Pharmacol. 35, 765 (1983).
R. L. Clarke, A. J. Gambino, A. K. Pierson, and S. J. Daum, J. Med. Chem. 21, 1235 (1978).
R. E. Bowman, H. O. J. Collier, I. M. Lockhart, C. Schneider, N. E. Webb, and M. Wright, J. Med. Chem. 16, 1177 (1973).
M. Takeda, H. Inoue, K. Noguchi, Y. Honma, M. Kawamori, G. Tsukamoto, Y. Yamawaki, S. Saito, K. Aoe, T. Date, S. Nurimoto, and G. Hayashi, J. Med. Chem. 20, 221 (1977).
J. L. Malis, M. E. Rosenthale, and M. I. Gluckman, J. Pharmacol Exp. Ther. 194, 488 (1975).
J. P. Yardley, H. Fletcher, and P. B. Russell, Experientia 34, 1124 (1978).
D. della Bella, V. Ferrari, V. Frigeni, and P. Lualdi, Nature New Biol 241, 282 (1973).
C. B. Pert, D. L. Bowie, A. Pert, J. L. Morell, and E. Gross, Nature 269, 73 (1977).
E. F. Hahn, J. Fishman, Y. Shiwaku, F. F. Foldes, H. Nagashima, and D. Duncalf, Res. Comm. Chem. Path. Pharmacol. 18, 1 (1977).
P. Belton, R. Cotton, M. B. Giles, J. J. Gormley, L. Miller, J. S. Shaw, D. Timms, and A. Wilkinson, Life Sci. 33, Sup. J, 443 (1983).
P. E. Gilbert and W. R. Martin, J. Pharmacol. Exp. Ther. 198, 66 (1976).
D. Romer, H. Buscher, R. C. Hill, R. Maurer, T. J. Petcher, H. B. A. Welle, H. C. C. K. Bakel, and A. M. A. Kerman, Life Sci. 27, 971 (1980).
H. H. Swain and M. H. Seevers in Addendum to the 1974 Proc. Comm. Problems of Drug Dependence, p. 1168, National Academy of Science, Washington, D. C. (1974).
J. H. Woods, C. B. Smith, F. Medzihradsky, and H. H. Swain, in: Mechanisms of Pain and Analgesic Compounds (R. F. Beers and E. G. Bassett, eds.), p. 4, Raven Press, New York (1979).
D. Romer, R. Maurer, and R. C. Hill, paper presented to a symposium on Kappa receptors and their ligands, Faculty of Pharmacy, Toulouse, April 1982.
T. Oka, K. Negishi, S. Mitsuaki, T. Matsumiya, T. Inazu, and M. Ueki, Eur. J. Pharmacol. 73, 235 (1981).
H. Merz, A. Langbein, K. Stockhaus, and H. Wick, Adv. Biochem. Psychopharmacol. 8, 91 (1974).
J. A. H. Lord, A. A. Waterfield, J. Hughes, and H. W. Kosterlitz, Nature 267, 495 (1977).
H. W. Kosterlitz, S. J. Paterson, and L. E. Robson, Br. J. Pharmacol. 73, 939 (1981).
H. B. A. Welle, private communication; Dutch Patent Application 7804509.
H. Merz and K. Stockhaus, J. Med. Chem. 22, 1475 (1979).
H. Merz, paper presented at Toulouse symposium (1982), (see ref. 110).
J. Szmuszkovicz and P. F. Von Voigtlander, J. Med. Chem. 25, 1125 (1982).
P. F. Von Voigtlander, R. A. Lahti, and J. H. Ludeus, J. Pharmacol. Exp. Ther. 224, 7 (1983).
N. J. Harper, G. B. A. Veitch, and D. G. Wibberley, J. Med. Chem. 17, 1118 (1974).
D. Romer, H. H. Buscher, R. C. Hill, R. Maurer, T. J. Petcher, H. Zengner, W. Benson, E. Finner, W. Milkowski, and P. W. Thies, Nature 298, 759 (1982).
D. Romer, H. H. Buscher, R. C. Hill, R. Maurer, T. J. Petcher, H. Zengner, W. Benson, E. Finner, W. Milkowski, and P. W. Thies, Life Sci. 31, 1217 (1982).
C. Chavkin, I. F. James, and A. Goldstein, Science 215, 413 (1982).
A. D. Corbett, S. J. Paterson, A. T. McKnight, J. Magnan, and H. W. Kosterlitz, Nature 299, 79 (1982).
S. J. Ward, A. K. Pierson, and W. F. Michne, Life Sci. 33, Suppl. 303 (1983).
W. F. Michne, R. T. Lewis, S. J. Michalec, A. K. Pierson, and F. J. Rosenberg, J. Med. Chem. 22, 1158 (1979).
M. Erez, A. E. Takemori, and P. S. Portoghese, J. Med. Chem. 25, 847 (1982).
M. S. Gold, C. A. Dackis, A. L. C. Pottash, H. H. Sternbach, and W. J. Anitto, Med. Res. Revs. 2, 211 (1982).
A. E. Takemori, in: Narcotic Antagonists, p. 335 (1974), (see ref. 26).
A. E. Jacobson, B. S. Bajwa, R. A. Streaty, W. A. Klee, and K. C. Rice, Life Sci. 33, Suppl. 1,159 (1983).
P. R. Crabbendam, H. C. Beyerman, T. S. Lie, and L. Maat, Recl. Trav. Chim. Pays-Bas, 102, 135 (1985).
G. Toth, M. Kramer, F. Sirokman, A. Borsodi, and A. Ronai, J. Label, Comp. Radiopharm. 19, 1021 (1982).
S. Galetta, G. S. F. Ling, L. Wölfin, and G. W. Pasternak, Life Sci. 31, 1389 (1982).
V. M. Kolb and J. R. Gober, Life Sci. 33, Suppl. 1, 419 (1983).
J. Telford, C. N. Papadopoulos, and A. S. Keats, J. Pharmacol Exp. Ther. 133, 106 (1961).
E. Waldmann and P. A. L. Horsfall, Br. Med. J. 1, 642 (1977).
P. Y. Law, D. S. Horn, and H. H. Loh, Molec. Pharmacol 23, 26 (1983).
E. L. Eliel, S. Morris-Natschke, and V. M. Kolb, Org. Magn. Resort. 22, 258 (1984).
E. Hazum, J. J. Sabatka, K.-I. Chang, D. A. Brent, and J. W. Findlay, Science 213, 1010 (1981).
C. Zioudron, R. A. Streaty, and W. A. Klee, J. Biol Chem. 254, 2556 (1979).
J. H. Boublik, M. J. Quinn, J. A. Clements, A. C. Herington, K. N. Wynne, and J. W. Funder, Nature 301, 246 (1983).
N. Upton, R. D. E. Sewell, and P. S. J. Spencer, IRCS Med. Sci. 9, 614 (1981).
R. D. E. Sewell and N. Upton, Br. J. Pharmacol. 80, 558P (1983).
D. Romer, private communication.
H. Merz, in: X-Ray Crystallography and Drug Action (A. S. Horn and C. J. De Ranter, eds.), p. 302, Clarendon Press, Oxford (1984).
S. R. Childers, J. Pharmacol Exp. Ther. 230, 684 (1984).
R. Dixon, J. Hsiao, W. Taaffe, E. Hahn, and R. Tuttle, J. Pharm. Sci. 73, 1645 (1984).
J. Knoll, S. Furst, and S. Marklett, Arch. Int. Pharmacodyn. Ther. 228, 268 (1977).
L. Kerecsen and J. Knoll, Pharmacology 22, 8 (1981).
S. J. Ward, A. K. Pierson, and W. F. Michne, paper presented at INRC meeting, Cambridge, UK (July 1984).
P. S. Portoghese and A. E. Takemori, paper presented at INRC meeting, Cambridge UK (July 1984).
T.-P. Su, T. H. Clements and C. W. Gorodetzki, Life Sci. 28, 2519 (1981).
H. W. Kosterlitz, A. A. Waterfield, and V. Berthoud, in: Narcotic Antagonists, p. 319 (1974) (see ref. 26 for details).
A. D. Corbett, M. G. C. Gillan, H. W. Kosterlitz, A. T. McKnight, S. J. Paterson, and L. E. Robson, Br. J. Pharmacol. 83, 271 (1984).
L. E. Robson, R. W. Foote, R. Maurer, and H. W. Kosterlitz, Neurosci. 12, 621 (1984).
P. S. Portoghese and A. E. Takemori, in: Chemical Regulation of Biological Mechanisms (A. M. Creighton and S. Turner, eds.), p. 181, Royal Society of Chemistry, London (1982).
S. J. Ward and A. E. Takemori, J. Pharmacol Exp. Ther. 224, 525 (1983).
S. J. Ward, private communication.
R. A. Olofson, R. C. Schnur, L. Bunes, and J. P. Pepe, Tetrahedron Lett. 1567 (1977).
E. R. Garrett and V. R. Chandran, J. Pharm. Sci. 74, 515 (1985).
E. J. Cone, C. W. Gorodetzky, W. D. Darwin, and W. F. Buchwald, J. Pharm. Sci. 73, 243 (1984).
E. R. Garrett and A. El-Koussi, J. Pharm. Sci. 74, 50 (1985).
M. D. Aceto, E. L. May, L. S. Harris, A. E. Jacobson, and H. Awaya, J. Pharm. Sci. 73, 1864 (1984).
S. Archer, A. Seyed-Mozaffori, S. Ward, H. W. Kosterlitz, S. J. Paterson, A. T. McNight, and A. D. Corbett, J. Med. Chem. 28, 947 (1985).
G. W. Kirby and D. McLean, J. Chem. Soc. Perkin Trans I, 1443 (1985) and references there cited.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer Science+Business Media New York
About this chapter
Cite this chapter
Casy, A.F., Parfitt, R.T. (1986). Antagonists, Dualists, and Kappa Agonists. In: Opioid Analgesics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0585-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0585-7_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0587-1
Online ISBN: 978-1-4899-0585-7
eBook Packages: Springer Book Archive